Close Menu

Ohio State

This Week in Cell

In Cell this week: DNA-based survey of marine virus genomes,  single-cell atlas of tumor proteomic profiles, and more.

Suit for Chair

According to Retraction Watch, Ohio State University's Carlo Croce is suing to be reinstated as department chair.

Ohio State University researchers found that a phosphorothioate-modified DNA-crRNA duplex completely blocked the function of Cas12a.

A brief recap of Genetics/Genomics news the week of Dec 14, 2018: AstraZeneca, NeoGenomics, Fluidigm, Luminex, Petco Foundation, and SQI Diagnostics

Croce Out as Chair

Retraction Watch reports Ohio State has pushed Carlo Croce to step down as department chair.

Mostly Dismissed

Retraction Watch reports that a judge dismissed most of the lawsuit Ohio State University's Carlo Croce brought against the New York Times.

Patients whose tumors had methylated MGMT promoters were more likely to survive than those that did not after combination treatment with radiotherapy and temozolomide.

Science reports that Ohio State University cancer researcher Ching-Shih Chen resigned due to misconduct findings.

Prospective panel sequencing on colorectal cancer patients picked up Lynch syndrome with sensitivity and specificity that met or exceeded gene-by-gene tests.

The researchers plan to add the MSI detection capabilities to an NGS panel and will use the information to guide cancer patients to precision medicine trials.

Pages

The former commissioner of the FDA has returned to the venture capital firm New Enterprise Associates as a special partner on the healthcare investment team.

Astronauts have edited yeast genes on the International Space Station in an experiment designed to show how cells repair themselves in space.

Emory University has found that two of its researchers failed to divulge they had received funds from China, according to the Atlanta Journal-Constitution.

In Science this week: influence of the nuclear genome on human mitochondrial DNA, and more.